Skip to main content
. 2014 Feb 11;2(3):449–453. doi: 10.3892/mco.2014.256

Figure 1.

Figure 1.

MRI imaging of brain metastasis. MRI imaging from a male patient (patient no. 3, Tables I and II). The cranial tumor exhibited a partial response (PR) after receiving one cycle of erlotinib plus pemetrexed/cisplatin. Left panel, prior to treatment. Right panel, image after one treatment cycle. MRI, magnetic resonance imaging.